CN102648906A - 舒尼替尼在制备乙酰胆碱酯酶抑制剂中的应用 - Google Patents

舒尼替尼在制备乙酰胆碱酯酶抑制剂中的应用 Download PDF

Info

Publication number
CN102648906A
CN102648906A CN2012101537630A CN201210153763A CN102648906A CN 102648906 A CN102648906 A CN 102648906A CN 2012101537630 A CN2012101537630 A CN 2012101537630A CN 201210153763 A CN201210153763 A CN 201210153763A CN 102648906 A CN102648906 A CN 102648906A
Authority
CN
China
Prior art keywords
acetylcholine
preparation
present
sutent
sunitinib
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101537630A
Other languages
English (en)
Chinese (zh)
Inventor
杨永亮
牛铭山
毛磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University of Technology
Original Assignee
Dalian University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University of Technology filed Critical Dalian University of Technology
Priority to CN2012101537630A priority Critical patent/CN102648906A/zh
Publication of CN102648906A publication Critical patent/CN102648906A/zh
Pending legal-status Critical Current

Links

Images

CN2012101537630A 2012-05-17 2012-05-17 舒尼替尼在制备乙酰胆碱酯酶抑制剂中的应用 Pending CN102648906A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101537630A CN102648906A (zh) 2012-05-17 2012-05-17 舒尼替尼在制备乙酰胆碱酯酶抑制剂中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101537630A CN102648906A (zh) 2012-05-17 2012-05-17 舒尼替尼在制备乙酰胆碱酯酶抑制剂中的应用

Publications (1)

Publication Number Publication Date
CN102648906A true CN102648906A (zh) 2012-08-29

Family

ID=46691141

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101537630A Pending CN102648906A (zh) 2012-05-17 2012-05-17 舒尼替尼在制备乙酰胆碱酯酶抑制剂中的应用

Country Status (1)

Country Link
CN (1) CN102648906A (ru)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101022799A (zh) * 2004-07-19 2007-08-22 约翰·霍普金斯大学 供免疫抑制的flt3抑制剂
WO2010017541A2 (en) * 2008-08-08 2010-02-11 The Johns Hopkins University Compositions and methods for treatment of neurodegenerative disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101022799A (zh) * 2004-07-19 2007-08-22 约翰·霍普金斯大学 供免疫抑制的flt3抑制剂
WO2010017541A2 (en) * 2008-08-08 2010-02-11 The Johns Hopkins University Compositions and methods for treatment of neurodegenerative disease

Similar Documents

Publication Publication Date Title
Zhang et al. Multi-target design strategies for the improved treatment of Alzheimer's disease
Dedeoglu et al. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis
Schneider Treatment of Alzheimer's disease with cholinesterase inhibitors
US11419850B2 (en) Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
Kuppusamy et al. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer’s disease
CN103501785B (zh) 用于治疗脑肿瘤的csf-1r抑制剂
Alam et al. Pharmacological and computer-aided studies provide new insights into Millettia peguensis Ali (Fabaceae)
Costa et al. N-acetylcysteine protects memory decline induced by streptozotocin in mice
CN109689044A (zh) 用于治疗胰腺癌的糖皮质激素受体调节剂
CN102245615A (zh) 治疗肝性脑病的方法
McLaughlin et al. The cell cycle, chromatin and cancer: mechanism-based therapeutics come of age
Costigan et al. Analgesia by inhibiting tetrahydrobiopterin synthesis
US20130172398A1 (en) Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases
Garg et al. Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer
Chen et al. Sulforaphane attenuates EGFR signaling in NSCLC cells
Marchetti et al. Association between proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumors: a randomized phase II trial
CN113038950A (zh) 用于治疗神经母细胞瘤的Aurora A激酶抑制剂
Islam et al. Human serum albumin reduces the potency of acetylcholinesterase inhibitor based drugs for Alzheimer's disease
JP6063472B2 (ja) 骨髄増殖性新生物形成および慢性骨髄性白血病を含む、トランスデューシンβ様タンパク質１（ＴＢＬ１）活性に関連する疾患および障害の処置のための方法
Ou et al. Clinical activity of crizotinib in patients with advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement
CN110179859A (zh) 防己提取物及防己诺林碱在制药中的应用
CN102648906A (zh) 舒尼替尼在制备乙酰胆碱酯酶抑制剂中的应用
CN102970996A (zh) 用于减轻汞毒性的组合物和方法
Abelson et al. Comparative Effects of Citrovorum Factor and Carboxypeptidase G₁ on Cerebrospinal Fluid-Methotrexate Pharmacokinetics 1, 2
CN102657655B (zh) 嘧啶胺类化合物在制备乙酰胆碱酯酶抑制剂中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120829